| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LIN | Ordinary Shares | Options Exercise | $0 | +6.34K | +9.28% | $0.00 | 74.6K | Mar 10, 2025 | Direct | F1 |
| transaction | LIN | Ordinary Shares | Tax liability | -$1.31M | -2.79K | -3.74% | $468.77 | 71.8K | Mar 10, 2025 | Direct | F2 |
| transaction | LIN | Ordinary Shares | Options Exercise | $0 | +19K | +26.45% | $0.00 | 90.8K | Mar 10, 2025 | Direct | F3 |
| transaction | LIN | Ordinary Shares | Tax liability | -$4.13M | -8.8K | -9.69% | $468.77 | 82K | Mar 10, 2025 | Direct | F2 |
| transaction | LIN | Ordinary Shares | Options Exercise | $0 | +11.7K | +14.21% | $0.00 | 93.7K | Mar 10, 2025 | Direct | F3 |
| transaction | LIN | Ordinary Shares | Tax liability | -$2.53M | -5.4K | -5.77% | $468.77 | 88.3K | Mar 10, 2025 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LIN | Performance Share Units (ROC) | Award | $0 | +19K | $0.00 | 19K | Mar 10, 2025 | Ordinary Shares | 19K | $0.00 | Direct | F4 | |
| transaction | LIN | Performance Share Units (ROC) | Options Exercise | $0 | -19K | -100% | $0.00 | 0 | Mar 10, 2025 | Ordinary Shares | 19K | $0.00 | Direct | F4 |
| transaction | LIN | Performance Share Units (RTSR) | Award | $0 | +11.7K | $0.00 | 11.7K | Mar 10, 2025 | Ordinary Shares | 11.7K | $0.00 | Direct | F5 | |
| transaction | LIN | Performance Share Units (RTSR) | Options Exercise | $0 | -11.7K | -100% | $0.00 | 0 | Mar 10, 2025 | Ordinary Shares | 11.7K | $0.00 | Direct | F5 |
| transaction | LIN | Restricted Stock Units | Options Exercise | $0 | -6.34K | -100% | $0.00 | 0 | Mar 10, 2025 | Ordinary Shares | 6.34K | Direct | F6, F7 | |
| transaction | LIN | Restricted Stock Units | Award | $0 | +6.36K | $0.00 | 6.36K | Mar 7, 2025 | Ordinary Shares | 6.36K | $0.00 | Direct | F8 | |
| transaction | LIN | Stock Options (right to buy) | Award | $0 | +44.7K | $0.00 | 44.7K | Mar 7, 2025 | Ordinary Shares | 44.7K | $468.77 | Direct | F11 | |
| holding | LIN | Restricted Stock Units | 6.41K | Mar 7, 2025 | Ordinary Shares | 6.41K | Direct | F9 | ||||||
| holding | LIN | Restricted Stock Units | 7.02K | Mar 7, 2025 | Ordinary Shares | 7.02K | Direct | F10 | ||||||
| holding | LIN | Stock Options (right to buy) | 41.5K | Mar 7, 2025 | Ordinary Shares | 41.5K | $465.29 | Direct | F12 | |||||
| holding | LIN | Stock Options (right to buy) | 46.4K | Mar 7, 2025 | Ordinary Shares | 46.4K | $354.14 | Direct | F13 | |||||
| holding | LIN | Stock Options (right to buy) | 54.9K | Mar 7, 2025 | Ordinary Shares | 54.9K | $270.99 | Direct | F14 | |||||
| holding | LIN | Stock Options (right to buy) | 41K | Mar 7, 2025 | Ordinary Shares | 41K | $253.68 | Direct | F15 | |||||
| holding | LIN | Stock Options (right to buy) | 37.6K | Mar 7, 2025 | Ordinary Shares | 37.6K | $173.13 | Direct | F16 | |||||
| holding | LIN | Stock Options (right to buy) | 15.5K | Mar 7, 2025 | Ordinary Shares | 15.5K | $176.63 | Direct | F17 | |||||
| holding | LIN | Deferred Stock Units | 406 | Mar 7, 2025 | Ordinary Shares | 406 | $0.00 | Direct | F6, F18 |
| Id | Content |
|---|---|
| F1 | Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2022. |
| F2 | Ordinary shares withheld from the payout to cover tax withholdings. |
| F3 | Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2022. |
| F4 | The PSU paid out on March 10, 2025 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2022-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022. |
| F5 | The PSU paid out on March 10, 2025 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2022-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022. |
| F6 | Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis. |
| F7 | Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis |
| F8 | Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis. |
| F9 | Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis. |
| F10 | Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis. |
| F11 | This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026. |
| F12 | This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025. |
| F13 | This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024. |
| F14 | This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023. |
| F15 | This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022. |
| F16 | Stock options have been granted pursuant to the Business Combination Agreement among Praxair, Inc., Linde AG, Linde plc and certain of their affiliates, dated June 1, 2017, as amended (the "BCA"). The stock options replace certain previously granted equity awards granted by Linde AG that were terminated in connection with the closing of the Business Combination of Praxair, Inc. and Linde AG that occurred on October 31, 2018. A more detailed explanation of these stock option replacement awards is discussed in the Linde plc Registration Statement on Form S-4 (Amendment No. 4) filed with the SEC on August 11, 2017 under the section titled "The Business Combination - Interests of Directors, Board Members and Executive Officers in the Business Combination - Linde AG - Treatment of Equity Awards" on pages 183-187. |
| F17 | This option vests over three years in three consecutive equal annual installments beginning March 20, 2020. |
| F18 | Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan. |